New and existing digital health products including software apps have to be classified from May 2020 via notified bodies in the European Union. Ulrich Gassner, Professor of Public Law at Universität Augsburg (DE) has been dealing with business strategies in grey zones where non-regulated applications for health overlap with medical devices. With an updated introduction about public opinion and GAFA-attitudes by B2Bioworld.Read more ...
Personalised medicine? It’s about health. A systems look at human genetic diagnostics and the road ahead for next-generation sequencing by Leroy Hood, President of the Institute for Systems Biology at Seattle, Washington (US)Read more ...
Sascha Beutel, Institut für Technische Chemie Hannover with students and industry partners has been exploring do-it-yourself of laboratory environments. B2Bioworld enquired more obstinateRead more ...
Ulrich Betz, Vice President Department Head Innovation & Entrepreneurship Incubator; Merck BiopharmaRead more ...
Everyone agrees upon the need of innovation. However, few follow it up. Georges Haour termed it the "innovation paradox". In the exclusive interview with B2Bioworld, Günter von Au offers his opinion on renewing Clariant and turning R&D on battery storage, catalysts, or biofuels into viable solutions – meeting still unmet needs in the energy sector.Read more ...
Science can be fun to read, but be aware. Book Review / free of charge
Book Review / free of charge
Schüler’s Compendium on German biotech industry - free of charge